RNTX (STOCKS)

    Rein Therapeutics, Inc. Common Stock

    $1.170000
    -0.010000 (-0.85%)
    Prev close: $1.180000
    Company Information
    Exchange
    XNAS
    Sector
    Health Technology
    Industry
    Pharmaceuticals: Major
    CEO
    Brian J. Windsor
    Asset Type
    stocks
    Website
    Visit
    Fundamentals
    Market Cap
    $29.97M
    Employees
    11
    P/E (TTM)
    -0.44
    P/B (TTM)
    25.03
    Dividend Yield
    Technical Indicators
    SMA 10
    SMA 20
    SMA 50
    EMA 9
    EMA 21
    RSI
    MACD State

    Analyst Recommendations
    2
    Strong Buy
    4
    Buy
    2
    Hold
    0
    Sell
    Recent News

    No recent news found for this ticker.

    Earnings Surprises
    Period Actual Estimate Surprise Surprise %
    Sep 2025 (Q3)
    $-0.21 $-0.24 +0.0348 +14.22%
    Jun 2025 (Q2)
    $-0.28 $-0.22 -0.0556 -24.78%
    Mar 2025 (Q1)
    $-0.25 $-0.25 -0.0001 -0.04%
    Dec 2024 (Q4)
    $-2.20 $-0.14 -2.0582 -1,451.48%